EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Left Atrial Appendage Thrombus as a Marker of Disease Severity in 500 Patients with Atrial Fibrillation on Oral Anticoagulation: A 13-Year Follow-Up Study

Łukasz Turek iD, Marcin Sadowski iD, Jacek Kurzawski iD, Marianna Janion

Journal of Clinical Medicine · 05.09.2024 · 13 (17) · 5258

DOI: 10.3390/jcm13175258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 05.09.2024. Verfasst von Łukasz Turek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Collegium Medicum, Jan Kochanowski University, 25-369 Kielce, Poland. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: Whether left atrial appendage thrombus (LAAT) in patients with atrial fibrillation (AF) on chronic anticoagulation significantly increases cardiovascular risk is unknown. This study aimed to assess LAAT prevalence and its predictive role in cardiovascular events among consecutive anticoagulated patients with AF admitted for electrical cardioversion.

Methods

This prospective study included 500 patients. The primary outcome was LAAT on transesophageal echocardiography. Patients were followed up for a median of 1927.5 (interquartile range 1004–2643) days to assess cardiovascular events.

Results

LAAT was detected in 65 (13%) patients. No significant differences in stroke, transient ischemic attack, systemic thromboembolic events, or myocardial infarction prevalence were observed between patients with AF with and without LAAT. Hospitalization for heart failure (HF) was more frequent in patients with LAAT than in those without LAAT; however, the effect of LAAT on HF hospitalization was not statistically significant. Patients with LAAT had a significantly higher risk of cardiovascular death than those without LAAT. LAAT and greater left atrial (LA) diameter were associated with higher rates of cardiovascular death. The independent HF hospitalization predictors were greater LA diameter, lower left ventricular ejection fraction (LVEF), and estimated glomerular filtration rate (eGFR).

Conclusions

Patients with AF who received anticoagulation therapy showed a high prevalence of LAAT. LAAT and greater LA diameter were associated with significantly higher rates of cardiovascular death. LAAT, greater LA diameter, lower LVEF, and lower eGFR were associated with poor prognosis in anticoagulated patients with AF and were predictors of disease severity.

Schlagwörter

Stichwörter der Autor:innen

anticoagulationatrial fibrillationcardiovascular deathheart failureleft atrial appendage thrombus

Autor:innen und Institutionen

  • Collegium Medicum, Jan Kochanowski University, 25-369 Kielce, Poland.

ORCID-Profile: Łukasz Turek, Marcin Sadowski, Jacek Kurzawski

Zitieren

APA

Turek, Ł., Sadowski, M., Kurzawski, J., & Janion, M. (2024). Left Atrial Appendage Thrombus as a Marker of Disease Severity in 500 Patients with Atrial Fibrillation on Oral Anticoagulation: A 13-Year Follow-Up Study. Journal of Clinical Medicine, 13(17), 5258. https://doi.org/10.3390/jcm13175258

Vancouver

Turek Ł, Sadowski M, Kurzawski J, Janion M. Left Atrial Appendage Thrombus as a Marker of Disease Severity in 500 Patients with Atrial Fibrillation on Oral Anticoagulation: A 13-Year Follow-Up Study. Journal of Clinical Medicine. 2024;13(17):5258. doi:10.3390/jcm13175258

BibTeX
@article{Turek2024,
  author = {Turek, Łukasz and Sadowski, Marcin and Kurzawski, Jacek and Janion, Marianna},
  title = {Left Atrial Appendage Thrombus as a Marker of Disease Severity in 500 Patients with Atrial Fibrillation on Oral Anticoagulation: A 13-Year Follow-Up Study},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {17},
  pages = {5258},
  doi = {10.3390/jcm13175258}
}
Kostenlos starten →